Safety and Pharmacokinetics of Calaspargase Pegol in Adults with Newly Diagnosed Philadelphia-Negative ALL: A Phase 2/3 Study
Year: 2021
Type: conference-abstract
Source: Blood
Institutions: University of Chicago, University of Chicago Medical Center, Memorial Sloan Kettering Cancer Center, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, NYU Langone Health, New York University, Seattle Cancer Care Alliance, University of Washington, Fred Hutch Cancer Center, City Of Hope National Medical Center, City of Hope, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Institut de Recherches Internationales Servier (France), Dana-Farber Cancer Institute
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3217097929
